Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma

Cell Reports

Volumn 7, Issue 1, 2014, Pages 104-112

  Chen, Xiang ^a   Bahrami, Armita ^a   Pappo, Alberto ^a   Easton, John ^a   Dalton, James ^a   Hedlund, Erin ^a   Ellison, David ^a   Shurtleff, Sheila ^a   Wu, Gang ^a   Wei, Lei ^a   Parker, Matthew ^a   Rusch, Michael ^a   Nagahawatte, Panduka ^a   Wu, Jianrong ^a   Mao, Shenghua ^a   Boggs, Kristy ^a   Mulder, Heather ^a   Yergeau, Donald ^a   Lu, Charles ^c   Ding, Li ^c   Edmonson, Michael ^a   Qu, Chunxu ^a   Wang, Jianmin ^a   Li, Yongjin ^a   Navid, Fariba ^a   Daw, Najat C ^b   Mardis, Elaine R ^c   Wilson, Richard K ^c,d   Downing, James R ^a   Zhang, Jinghui ^a   Dyer, Michael A ^a,e   more..

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MO   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOBLASTOMA PROTEIN; DNA;

ANEUPLOIDY; ARTICLE; ATRX GENE; CARCINOGENESIS; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DLG2 GENE; GENE; GENE SEQUENCE; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; INTRON; KATAEGIS; MUTATION; MUTATIONAL ANALYSIS; OSTEOSARCOMA; PRIORITY JOURNAL; RB1 GENE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; ADOLESCENT; BONE TUMOR; CHILD; COPY NUMBER VARIATION; DISEASE COURSE; GENETICS; HUMAN GENOME; METASTASIS; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; BONE NEOPLASMS; CARCINOGENESIS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DNA COPY NUMBER VARIATIONS; DNA, NEOPLASM; GENOME, HUMAN; HUMANS; MUTATION; NEOPLASM METASTASIS; OSTEOSARCOMA; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84898027965     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.03.003     Document Type: Article

References (20)

1. Baca S.C., Prandi D., Lawrence M.S., Mosquera J.M., Romanel A., Drier Y., Park K., Kitabayashi N., MacDonald T.Y., Ghandi M., et al. Punctuated evolution of prostate cancer genomes. Cell 2013, 153:666-677.
2. Berger M.F., Lawrence M.S., Demichelis F., Drier Y., Cibulskis K., Sivachenko A.Y., Sboner A., Esgueva R., Pflueger D., Sougnez C., et al. The genomic complexity of primary human prostate cancer. Nature 2011, 470:214-220.
3. Campbell P.J., Yachida S., Mudie L.J., Stephens P.J., Pleasance E.D., Stebbings L.A., Morsberger L.A., Latimer C., McLaren S., Lin M.L., et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010, 467:1109-1113.
4. Chen X., Steward E., Shelat A., Qu C., Bahrami A., Hatley M., Wu G., Bradley C., McEvoy J., Pappo A., et al. Targeting oxidative stress in embryonal rhabdomyosarcoma. Cancer Cell 2013, 24:710-724. St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project.
5. Cheung N.K., Zhang J., Lu C., Parker M., Bahrami A., Tickoo S.K., Heguy A., Pappo A.S., Federico S., Dalton J., et al. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA 2012, 307:1062-1071.
6. Downing J.R., Wilson R.K., Zhang J., Mardis E.R., Pui C.H., Ding L., Ley T.J., Evans W.E. The Pediatric Cancer Genome Project. Nat. Genet. 2012, 44:619-622.
7. Hicks M.J., Roth J.R., Kozinetz C.A., Wang L.L. Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome. J.Clin. Oncol. 2007, 25:370-375.
8. Kleinerman R.A., Tucker M.A., Tarone R.E., Abramson D.H., Seddon J.M., Stovall M., Li F.P., Fraumeni J.F. ). Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J.Clin. Oncol. 2005, 23:2272-2279.
9. Lonardo F., Ueda T., Huvos A.G., Healey J., Ladanyi M. p53 andMDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate. Cancer 1997, 79:1541-1547.
10. McIntyre J.F., Smith-Sorensen B., Friend S.H., Kassell J., Borresen A.L., Yan Y.X., Russo C., Sato J., Barbier N., Miser J., et al. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J.Clin. Oncol. 1994, 12:925-930.
11. Meyers P.A., Schwartz C.L., Krailo M., Kleinerman E.S., Betcher D., Bernstein M.L., Conrad E., Ferguson W., Gebhardt M., Goorin A.M., et al. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J.Clin. Oncol. 2005, 23:2004-2011.
12. Miller C.W., Aslo A., Tsay C., Slamon D., Ishizaki K., Toguchida J., Yamamuro T., Lampkin B., Koeffler H.P. Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res. 1990, 50:7950-7954.
13. Nik-Zainal S., Alexandrov L.B., Wedge D.C., Van Loo P., Greenman C.D., Raine K., Jones D., Hinton J., Marshall J., Stebbings L.A., et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012, 149:979-993. Breast Cancer Working Group of the International Cancer Genome Consortium.
14. Ottaviani G., Jaffe N. The epidemiology of osteosarcoma. Cancer Treat. Res. 2009, 152:3-13.
15. Pounds S., Cheng C., Li S., Liu Z., Zhang J., Mullighan C. A genomic random interval model for statistical analysis of genomic lesion data. Bioinformatics 2013, 29:2088-2095.
16. Robinson G., Parker M., Kranenburg T.A., Lu C., Chen X., Ding L., Phoenix T.N., Hedlund E., Wei L., Zhu X., et al. Novel mutations target distinct subgroups of medulloblastoma. Nature 2012, 488:43-48.
17. Smith M.A., Seibel N.L., Altekruse S.F., Ries L.A., Melbert D.L., O'Leary M., Smith F.O., Reaman G.H. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J.Clin. Oncol. 2010, 28:2625-2634.
18. Stephens P.J., Greenman C.D., Fu B., Yang F., Bignell G.R., Mudie L.J., Pleasance E.D., Lau K.W., Beare D., Stebbings L.A., et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011, 144:27-40.
19. Wunder J.S., Gokgoz N., Parkes R., Bull S.B., Eskandarian S., Davis A.M., Beauchamp C.P., Conrad E.U., Grimer R.J., Healey J.H., et al. TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study. J.Clin. Oncol. 2005, 23:1483-1490.
20. Zhang J., Ding L., Holmfeldt L., Wu G., Heatley S.L., Payne-Turner D., Easton J., Chen X., Wang J., Rusch M., et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012, 481:157-163.